Alfonso
Garcia De Coca
Institute Catalá Oncología
Barcelona, EspañaInstitute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2024
-
Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma
Blood, Vol. 143, Núm. 7, pp. 597-603
2021
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589